Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02150746 · ClinicalTrials.gov registry record
Circulating Tumor Cells in Operative Blood
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 3
- Enrollment target
NCT02150746: Completed study, sponsored by University of Florida.
NCT02150746 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02150746 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
It is hypothesized that circulating tumor cells (CTCs) from pancreatic adenocarcinoma are released into the peritoneal cavity through blood lost during the surgical resection of these tumors resulting in peritoneal recurrence despite appropriate surgical resection. Targeting the mechanisms responsible for CTC adhesion to the peritoneum may result in inhibition of implantation and growth, thus preventing this mode of pancreatic cancer recurrence postoperatively.
Interventions
- PROCEDURE Peripheral/Central Venous Blood Draw
- PROCEDURE Peritoneal Wash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-02 |
What the finished NCT02150746 record still lists
NCT02150746 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Peripheral/Central Venous Blood Draw is the first listed.
NCT02150746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02150746 about?
NCT02150746 is a clinical study titled "Circulating Tumor Cells in Operative Blood". It is hypothesized that circulating tumor cells (CTCs) from pancreatic adenocarcinoma are released into the peritoneal cavity through blood lost during the surgical resection of these tumors resulting in peritoneal recurrence despite appropriate surgical resection. Targeting the mechanisms responsib...
What is the current status of trial NCT02150746?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2015-02. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02150746?
The interventions under investigation include: Peripheral/Central Venous Blood Draw (PROCEDURE), Peritoneal Wash (PROCEDURE).
Who is sponsoring clinical trial NCT02150746?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia